Collegium Pharmaceutical (COLL) Total Debt Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 92.83% |
| 10 | Collegium Pharmaceutical | 891.70 Mn | 742.38 Mn | 110.29 Mn | 20.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.02% |
| Mar 31, 2026 | 1.66% |
| Dec 31, 2025 | 0.65% |
| Sep 30, 2025 | -4.63% |
| Jun 30, 2025 | -1.14% |
| Mar 31, 2025 | -3.75% |
| Dec 31, 2024 | 77.50% |
| Sep 30, 2024 | 72.89% |
| Jun 30, 2024 | 33.18% |
| Mar 31, 2024 | 35.27% |
| Dec 31, 2023 | 37.00% |
| Sep 30, 2023 | 38.46% |
| Jun 30, 2023 | 39.69% |
| Mar 31, 2023 | 40.76% |
| Dec 31, 2022 | 265.19% |
| Sep 30, 2022 | 270.09% |
| Jun 30, 2022 | 274.84% |
| Mar 31, 2022 | 279.47% |
| Dec 31, 2021 | 112.29% |
| Sep 30, 2021 | -1.34% |